01/12/17 - Research project on precision medicine is funded by the Innovation Fund with 1.5 million euros
Scientists from BfArM and the DZNE will be working together and in cooperation with the statutory health insurance company Techniker Krankenkasse to investigate the influence of pharmacogenetic factors on the effectiveness and ...
01/05/17 - Protein Associated with Parkinson’s Travels from Brain to Gut
In a laboratory study, DZNE researchers have found that "alpha-synuclein", a protein involved in Parkinson's disease, is capable of travelling from the brain to the stomach using the vagus nerve as a conduit.
12/20/16 - Stroke: brain cells potentiate harmful electrical discharges
DZNE researchers have found that certain brain cells interact in a detrimental way during stroke. Harmful electrical discharges are thereby amplified.
12/14/16 - Early signs of Alzheimer’s detected in cerebrospinal fluid
Little is known about the role of the brain‘s immune system in Alzheimer's disease. DZNE researchers have now found an early immune response in individuals with a genetic predisposition to Alzheimer’s.
12/14/16 - Bonn-based neuroscientist awarded 1.8 million
Prof. Stefan Remy will receive the “Consolidator Grant” from the European Research Council (ERC). Remy plans to use the prize money on decoding single neuron function during behavior in mice.
12/06/16 - Speed data for the brain’s navigation system
DZNE researchers have identified a neural pathway that feeds speed information directly into the brain’s navigation system. They report on this in “Nature Neuroscience”.
25.11.16 - People with Parkinson’s show altered iron levels in their brains
In people with Parkinson’s disease iron distributes in an unusual way over the brain. This is the result of a study by researchers of the DZNE Magdeburg.
10/18/16 - Tweaking the Immune Response Might be a Key to Combat Neurodegeneration
Study suggests zebrafish might teach us how to tackle Alzheimer’s disease. Research group led by Caghan Kizil at the DZNE report on these findings in the journal “Cell Reports”.
10/17/16 - ChemDiv, Torrey Pines Investment and DZNE Announce Research Collaboration
DZNE, ChemDiv, Inc. and Torrey Pines Investment jointly announced today an agreement initiating a Research and Development collaboration targeting pathways and molecular mechanisms underlying neurological health and disease.
10/06/16 - Researchers activate repair program for nerve fibers
Scientists of the DZNE have succeeded in releasing a molecular brake that prevents the regeneration of nerve connections. Researchers led by neurobiologist Frank Bradke report on these findings in the journal Neuron.
10/06/16 - Aberrant Tau Proteins Put Neuronal Networks to Sleep: Drug “Rolofylline” a Possible Antidote
The report which is based on laboratory studies suggests that the drug “Rolofylline” could possibly alleviate learning and memory problems associated with aggregating Tau proteins.
09/22/16 - United against Dementia among Children and Adults
Learning from each other, joint research and as such make new therapies against childhood and senile dementia more tangible – this is what the DZNE and the NCL Foundation, now want to push ahead.
09/20/16 - Alzheimer’s: Cellular Mechanism Provides Explanation Model for Declining Memory Performance
Loss of neuronal contacts impairs nerve cells that control activity of the hippocampus. Martin Fuhrmann and co-workers report on these findings in “Neuron”.
09/01/16 - Federal President Gauck visits German Center for Neurodegenerative Diseases
Today Joachim Gauck and his partner Daniela Schadt informed themself about the diverse research at DZNE.
06/09/16 - A New Biomarker for Nerve Cell Damage
Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Hertie Institute for Clinical Brain Research and the University of Tübingen have identified proteins in the blood and cerebrospinal fluid that reflect ...
03/10/16 - UW-Madison delegation heads to DZNE in Germany for Alzheimer's, Dementia Research
A delegation of about a dozen UW-Madison research scientists will travel to Bonn and will share insights and information on the increasingly prevalent disease.
03/07/16 - DZNE and Orion Corporation start strategic collaboration
DZNE and Orion Corporation have agreed to start a strategic collaboration. They want to identify novel drug targets and develop treatments for neurodegenerative disorders.
02/17/16 - DZNE-research impacts German legislation
Scientific results of the DZNE-led study "Dementia Networks in Germany (DemNet-D)" were considered in a new German law to strengthen health care for people with dementia. This law enables statutory and private care insurance to ...
01/27/16 - Tübingen: DZNE Building for Brain Research opens under the auspices of Federal Research Minister Wanka, Science Minister Bauer and State Secretary Hofelich
High ranking representatives of politics and science inaugurated the new building for the DZNE on the grounds of the University Clinic Tübingen on January 27.
01/05/16 - Parkinson’s Disease: New Insights into a Traveling Protein
A laboratory study indicates that the main protein involved in Parkinson’s disease pathology does not behave as a ‘prion’ when overexpressed. Researchers led by Prof. Donato Di Monte report on this in the journal “BRAIN”.
12/18/15 - Magdeburg Brain Reseacher Emrah Düzel to coordinate the National Neuroimaging Network at the DZNE
So-called “Imaging techniques” are essential for understanding memory formation and cognition and the development of new therapies against brain diseases. The DZNE is now focusing its nationwide expertise in the field under the ...
12/17/15 - New insights into the molecular basis of memory
A DZNE study supports the hypothesis that memories are encoded with the help of chemical labels on the DNA. The findings are reported in „Nature Neuroscience“.
12/10/15 - DZNE Scientist Gets Most Important Research Award in Germany
The molecular biologist Frank Bradke, group leader at the DZNE and professor for neurobiology at the University of Bonn, will be awarded the “Gottfried Wilhelm Leibniz Prize”, which is endowed with 2.5 million euros.
11/24/15 - Science minister Hartmut Möllring inaugurates new MR-PET device
This morning, Saxony-Anhalt’s Minister of Science Hartmut Möllring inaugurated the new MR-PET device at the German Center for Neurodegenerative Diseases, site Magdeburg. The MR-PET device has opened up a whole new range of ...
11/23/15 - Laboratory study: Scientists from Cologne explore a new approach to prevent newborn epilepsies
Specific forms of epilepsy may manifest as early as in the first weeks of life. A new laboratory study shows that a preventive therapeutic strategy can be successful if it is applied within a time window critical to brain ...